The partnership with Runway Health commences April 2, 2026. It adds a new platform to the 60 Degrees Pharma ARAKODA marketing strategy, where eligible users can match their travel itinerary with a ...

All patients with autoimmune hemolytic anemia in a small study initially achieved remission, though two eventually relapsed, ...

Ouro Medicines, a clinical stage biotechnology company developing immune reset therapeutics for people living with chronic, ...

China: CAR T-cell therapy, already in use for certain B-cell-driven autoimmune diseases such as lupus, has now demonstrated success in autoimmune hemolytic anemia. In the pilot study of 11 patients, ...

Since it went on the market, the newer device has been the subject of several reports of hemolysis. This would seem counterintuitive given that hemolysis is thought to stem from the issue of ...

Initial results as promising as those in lupus and other non-cancer diseases driven by B c ...

Hutchmed Ltd. plans to file a second NDA in China for sovleplenib, a novel spleen tyrosine kinase inhibitor, based on positive phase II/III findings in warm antibody autoimmune hemolytic anemia.

Dr. Anju Goel, MD, MPH, is a public health consultant and physician with more than 10 years of experience in the California public health system. Heavy periods that cause blood loss can lead to iron ...